Protein quality control in Alzheimer's disease by the ubiquitin proteasome system

Progress in Neurobiology

Volumn 74, Issue 5, 2004, Pages 249-270

  De Vrij, F M S ^a   Fischer, D F ^a   Van Leeuwen, F W ^a   Hol, E M ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; CALMODULIN; CHYMOTRYPSIN; GAMMA INTERFERON; HYDROLASE; LIGASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; ORNITHINE DECARBOXYLASE; PEPTIDE DERIVATIVE; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN P53; TAU PROTEIN; TROPONIN C; UBIQUITIN; UBIQUITIN THIOLESTERASE;

ALZHEIMER DISEASE; BRAIN CORTEX; DEGENERATIVE DISEASE; ENZYME ACTIVITY; EUKARYOTIC CELL; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN QUALITY; QUALITY CONTROL; REVIEW;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEINS E; HUMANS; LEARNING; MUTATION; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; TAU PROTEINS; UBIQUITIN;

EID: 9744222883     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2004.10.001     Document Type: Review

References (235)

1. K. Aquilano, G. Rotilio, and M.R. Ciriolo Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu, Zn superoxide dismutase mutant involved in familial ALS J. Neurochem. 85 2003 1324 1335
2. P.V. Arriagada, J.H. Growdon, E.T. Hedley-Whyte, and B.T. Hyman Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease Neurology 42 1992 631 639
3. G. Asher, J. Lotem, L. Sachs, C. Kahana, and Y. Shaul Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1 Proc. Natl. Acad. Sci. U.S.A. 99 2002 13125 13130
4. C. Bancher, C. Brunner, H. Lassmann, H. Budka, K. Jellinger, F. Seitelberger, I. Grundke-Iqbal, K. Iqbal, and H.M. Wisniewski Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles Prog. Clin. Biol. Res. 317 1989 837 848
5. R. Beal, Q. Deveraux, G. Xia, M. Rechsteiner, and C. Pickart Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting Proc. Natl. Acad. Sci. U.S.A. 93 1996 861 866
6. U. Beffert, N. Aumont, D. Dea, S. Lussier-Cacan, J. Davignon, and J. Poirier Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures Brain Res. Mol. Brain Res. 68 1999 181 185
7. N. Benaroudj, E. Tarcsa, P. Cascio, and A.L. Goldberg The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes Biochimie 83 2001 311 318
8. N.F. Bence, R.M. Sampat, and R.R. Kopito Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552 1555
9. A. Bergman, E. Hansson, S.E. Pursglove, M.R. Farmery, L. Lannfelt, U. Lendahl, J. Lundkvist, and J. Naslund Pen-2 is sequestered in the endoplasmic reticulum and subjected to ubiquitylation and proteasome-mediated degradation in the absence of presenilin J. Biol. Chem. 279 2004 16744 16753
10. S.J. Berke, and H.L. Paulson Protein aggregation and the ubiquitin proteasome pathway: gaining the upper hand on neurodegeneration Curr. Opin. Genet. Dev. 13 2003 253 261
11. L.M. Bierer, P.R. Hof, D.P. Purohit, L. Carlin, J. Schmeidler, K.L. Davis, and D.P. Perl Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease Arch. Neurol. 52 1995 81 88
12. J. Bloom, V. Amador, F. Bartolini, G. DeMartino, and M. Pagano Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation Cell 115 2003 71 82
13. D.R. Borchelt, G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, T. Ratovitsky, C.M. Prada, G. Kim, S. Seekins, D. Yager, H.H. Slunt, R. Wang, M. Seeger, A.I. Levey, S.E. Gandy, N.G. Copeland, N.A. Jenkins, D.L. Price, S.G. Younkin, and S.S. Sisodia Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo Neuron 17 1996 1005 1013
14. H. Braak, R.A. de Vos, E.N. Jansen, H. Bratzke, and E. Braak Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog Brain Res. 117 1998 267 285
15. H. Braak, and K. Del Tredici Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation Neurobiol. Aging 25 2004 713 718
16. B.C. Braun, M. Glickman, R. Kraft, B. Dahlmann, P.M. Kloetzel, D. Finley, and M. Schmidt The base of the proteasome regulatory particle exhibits chaperone-like activity Nat. Cell Biol. 1 1999 221 226
17. W.J. Brecht, F.M. Harris, S. Chang, I. Tesseur, G.Q. Yu, Q. Xu, J. Dee Fish, T. Wyss-Coray, M. Buttini, L. Mucke, R.W. Mahley, and Y. Huang Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice J. Neurosci. 24 2004 2527 2534
18. L. Buee, T. Bussiere, V. Buee-Scherrer, A. Delacourte, and P.R. Hof Tau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain Res. Brain Res. Rev. 33 2000 95 130
19. M. Burbea, L. Dreier, J.S. Dittman, M.E. Grunwald, and J.M. Kaplan Ubiquitin and AP180 regulate the abundance of GLR-1 glutamate receptors at postsynaptic elements in C. elegans Neuron 35 2002 107 120
20. D.A. Butterfield, A. Castegna, C.M. Lauderback, and J. Drake Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death Neurobiol. Aging 23 2002 655 664
21. D.S. Campbell, and C.E. Holt Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation Neuron 32 2001 1013 1026
22. L. Canevari, A.Y. Abramov, and M.R. Duchen Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress Neurochem. Res. 29 2004 637 650
23. P. Cascio, M. Call, B.M. Petre, T. Walz, and A.L. Goldberg Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes EMBO J. 21 2002 2636 2645
24. A. Castegna, M. Aksenov, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71 J. Neurochem. 82 2002 1524 1532
25. V. Chau, J.W. Tobias, A. Bachmair, D. Marriott, D.J. Ecker, D.K. Gonda, and A. Varshavsky A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein Science 243 1989 1576 1583
26. Z. Chen, and C.M. Pickart A 25-kilodalton ubiquitin carrier protein (E2) catalyzes multi-ubiquitin chain synthesis via lysine 48 of ubiquitin J. Biol. Chem. 265 1990 21835 21842
27. D.H. Chui, H. Tanahashi, K. Ozawa, S. Ikeda, F. Checler, O. Ueda, H. Suzuki, W. Araki, H. Inoue, K. Shirotani, K. Takahashi, F. Gallyas, and T. Tabira Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation Nat. Med. 5 1999 560 564
28. C.H. Chung, and S.H. Baek Deubiquitinating enzymes: their diversity and emerging roles Biochem. Biophys. Res. Commun. 266 1999 633 640
29. K.K. Chung, Y. Zhang, K.L. Lim, Y. Tanaka, H. Huang, J. Gao, C.A. Ross, V.L. Dawson, and T.M. Dawson Parkin ubiquitinates the alpha-synuclein- interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease Nat. Med. 7 2001 1144 1150
30. A. Ciechanover The ubiquitin-proteasome proteolytic pathway Cell 79 1994 13 21
31. A. Ciechanover, and P. Brundin The ubiquitin proteasome system in neurodegenerative diseases Sometimes the chicken, sometimes the egg Neuron 40 2003 427 446
32. H. Cline Synaptic plasticity: importance of proteasome-mediated protein turnover Curr. Biol. 13 2003 R514 R516
33. P. Coffino Antizyme, a mediator of ubiquitin-independent proteasomal degradation Biochimie 83 2001 319 323
34. V. Colangelo, J. Schurr, M.J. Ball, R.P. Pelaez, N.G. Bazan, and W.J. Lukiw Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling J. Neurosci. Res. 70 2002 462 473
35. M. Colledge, E.M. Snyder, R.A. Crozier, J.A. Soderling, Y. Jin, L.K. Langeberg, H. Lu, M.F. Bear, and J.D. Scott Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression Neuron 40 2003 595 607
36. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
37. A.S. Crystal, V.A. Morais, R.R. Fortna, D. Carlin, T.C. Pierson, C.A. Wilson, V.M. Lee, and R.W. Doms Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation Biochemistry 43 2004 3555 3563
38. C.J. Cummings, E. Reinstein, Y. Sun, B. Antalffy, Y. Jiang, A. Ciechanover, H.T. Orr, A.L. Beaudet, and H.Y. Zoghbi Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice Neuron 24 1999 879 892
39. M.R. D'Andrea, R.G. Nagele, H.Y. Wang, and D.H. Lee Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex Neurosci. Lett. 333 2002 163 166
40. M.R. D'Andrea, R.G. Nagele, H.Y. Wang, P.A. Peterson, and D.H. Lee Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease Histopathology 38 2001 120 134
41. D.C. David, R. Layfield, L. Serpell, Y. Narain, M. Goedert, and M.G. Spillantini Proteasomal degradation of tau protein J. Neurochem. 83 2002 176 185
42. R. De Pril, D.F. Fischer, M.L. Maat-Schieman, B. Hobo, R.A. De Vos, E.R. Brunt, E.M. Hol, R.A. Roos, and F.W. Van Leeuwen Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases Hum. Mol. Genet. 13 2004 1803 1813
43. B. De Strooper Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex Neuron 38 2003 9 12
44. F.M. De Vrij, J.A. Sluijs, L. Gregori, D.F. Fischer, W.T. Hermens, D. Goldgaber, J. Verhaagen, F.W. Van Leeuwen, and E.M. Hol Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death FASEB J. 15 2001 2680 2688
45. A. DiAntonio, A.P. Haghighi, S.L. Portman, J.D. Lee, A.M. Amaranto, and C.S. Goodman Ubiquitination-dependent mechanisms regulate synaptic growth and function Nature 412 2001 449 452
46. M. Diaz-Hernandez, F. Hernandez, E. Martin-Aparicio, P. Gomez-Ramos, M.A. Moran, J.G. Castano, I. Ferrer, J. Avila, and J.J. Lucas Neuronal induction of the immunoproteasome in Huntington's disease J. Neurosci. 23 2003 11653 11661
47. C.A. Dickey, J.F. Loring, J. Montgomery, M.N. Gordon, P.S. Eastman, and D. Morgan Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice J. Neurosci. 23 2003 5219 5226
48. A. Dil Kuazi, K. Kito, Y. Abe, R.W. Shin, T. Kamitani, and N. Ueda NEDD8 protein is involved in ubiquitinated inclusion bodies J. Pathol. 199 2003 259 266
49. Q. Ding, and J.N. Keller Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins J. Neurochem. 77 2001 1010 1017
50. Q. Ding, and J.N. Keller Proteasomes and proteasome inhibition in the central nervous system Free Radic. Biol. Med. 31 2001 574 584
51. Q. Ding, J.J. Lewis, K.M. Strum, E. Dimayuga, A.J. Bruce-Keller, J.C. Dunn, and J.N. Keller Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival J. Biol. Chem. 277 2002 13935 13942
52. Q. Ding, K. Reinacker, E. Dimayuga, V. Nukala, J. Drake, D.A. Butterfield, J.C. Dunn, S. Martin, A.J. Bruce-Keller, and J.N. Keller Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress FEBS Lett. 546 2003 228 232
53. E.J. Dubelaar, R.W. Verwer, M.A. Hofman, J.J. Van Heerikhuize, R. Ravid, and D.E. Swaab ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus J. Neuropathol. Exp. Neurol. 63 2004 159 169
54. M. Farrer, P. Chan, R. Chen, L. Tan, S. Lincoln, D. Hernandez, L. Forno, K. Gwinn-Hardy, L. Petrucelli, J. Hussey, A. Singleton, C. Tanner, J. Hardy, and J.W. Langston Lewy bodies and parkinsonism in families with parkin mutations Ann. Neurol. 50 2001 293 300
55. J. Fergusson, M. Landon, J. Lowe, S.P. Dawson, R. Layfield, D.P. Hanger, and R.J. Mayer Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome Neurosci. Lett. 219 1996 167 170
56. K. Ferrell, C.R. Wilkinson, W. Dubiel, and C. Gordon Regulatory subunit interactions of the 26S proteasome, a complex problem Trends Biochem. Sci. 25 2000 83 88
57. D.F. Fischer, R.A. De Vos, R. Van Dijk, F.M. De Vrij, E.A. Proper, M.A. Sonnemans, M.C. Verhage, J.A. Sluijs, B. Hobo, M. Zouambia, E.N. Steur, W. Kamphorst, E.M. Hol, and F.W. Van Leeuwen Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain FASEB J. 17 2003 2014 2024
58. P.E. Fraser, G. Levesque, G. Yu, L.R. Mills, J. Thirlwell, M. Frantseva, S.E. Gandy, M. Seeger, P.L. Carlen, and P. St. George-Hyslop Presenilin 1 is actively degraded by the 26S proteasome Neurobiol. Aging 19 1998 S19 S21
59. P. Friedhoff, M. von Bergen, E.M. Mandelkow, and E. Mandelkow Structure of tau protein and assembly into paired helical filaments Biochim. Biophys. Acta 1502 2000 122 132
60. H. Fu, N. Reis, Y. Lee, M.H. Glickman, and R.D. Vierstra Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome EMBO J. 20 2001 7096 7107
61. H. Funato, M. Yoshimura, K. Kusui, A. Tamaoka, K. Ishikawa, N. Ohkoshi, K. Namekata, R. Okeda, and Y. Ihara Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease Am. J. Pathol. 152 1998 1633 1640
62. D.H. Geschwind Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? Neuron 40 2003 457 460
63. P. Giannakopoulos, F.R. Herrmann, T. Bussiere, C. Bouras, E. Kovari, D.P. Perl, J.H. Morrison, G. Gold, and P.R. Hof Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease Neurology 60 2003 1495 1500
64. B.I. Giasson, W. Bruening, H.D. Durham, and W.E. Mushynski Activation of stress-activated protein kinases correlates with neurite outgrowth induced by protease inhibition in PC12 cells J. Neurochem. 72 1998 1081 1087
65. S.D. Ginsberg, S.E. Hemby, V.M. Lee, J.H. Eberwine, and J.Q. Trojanowski Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons Ann. Neurol. 48 2000 77 87
66. M.H. Glickman, and A. Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol. Rev. 82 2002 373 428
67. A.L. Goldberg, P. Cascio, T. Saric, and K.L. Rock The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides Mol. Immunol. 39 2002 147 164
68. G. Goldstein, M. Scheid, U. Hammerling, D.H. Schlesinger, H.D. Niall, and E.A. Boyse Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells Proc. Natl. Acad. Sci. U.S.A. 72 1975 11 15
69. N. Gordon Alexander disease Eur. J. Paediatr. Neurol. 7 2003 395 399
70. J. Gotz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science 293 2001 1491 1495
71. G.K. Gouras, J. Tsai, J. Naslund, B. Vincent, M. Edgar, F. Checler, J.P. Greenfield, V. Haroutunian, J.D. Buxbaum, H. Xu, P. Greengard, and N.R. Relkin Intraneuronal Abeta42 accumulation in human brain Am. J. Pathol. 156 2000 15 20
72. L. Gregori, C. Fuchs, M.E. Figueiredo-Pereira, W.E. Van Nostrand, and D. Goldgaber Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro J. Biol. Chem. 270 1995 19702 19708
73. L. Gregori, J.F. Hainfeld, M.N. Simon, and D. Goldgaber Binding of amyloid beta protein to the 20S proteasome J. Biol. Chem. 272 1997 58 62
74. S.J. Grenfell, J.S. Trausch-Azar, P.M. Handley-Gearhart, A. Ciechanover, and A.L. Schwartz Nuclear localization of the ubiquitin-activating enzyme, E1, is cell-cycle-dependent Biochem. J. 300 Part 3 1994 701 708
75. M. Groll, and R. Huber Substrate access and processing by the 20S proteasome core particle Int. J. Biochem. Cell Biol. 35 2003 606 616
76. T. Grune, K. Merker, G. Sandig, and K.J. Davies Selective degradation of oxidatively modified protein substrates by the proteasome Biochem. Biophys. Res. Commun. 305 2003 709 718
77. C. Haass, A.Y. Hung, D.J. Selkoe, and D.B. Teplow Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor J. Biol. Chem. 269 1994 17741 17748
78. K. Haglund, P.P. Di Fiore, and I. Dikic Distinct monoubiquitin signals in receptor endocytosis Trends Biochem. Sci. 28 2003 598 603
79. R.Y. Hampton ER-associated degradation in protein quality control and cellular regulation Curr. Opin. Cell Biol. 14 2002 476 482
80. P.M. Handley-Gearhart, A.G. Stephen, J.S. Trausch-Azar, A. Ciechanover, and A.L. Schwartz Human ubiquitin-activating enzyme, E1 Indication of potential nuclear and cytoplasmic subpopulations using epitope-tagged cDNA constructs J. Biol. Chem. 269 1994 33171 33178
81. J. Hardy The uncertain anatomy of Alzheimer's disease Neurobiol. Aging 25 2004 719 720
82. T. Hartmann Intracellular biology of Alzheimer's disease amyloid beta peptide Eur. Arch. Psychiatry Clin. Neurosci. 249 1999 291 298
83. S. Hatakeyama, M. Yada, M. Matsumoto, N. Ishida, and K.I. Nakayama U box proteins as a new family of ubiquitin-protein ligases J. Biol. Chem. 276 2001 33111 33120
84. S. Hayashi, K. Wakabayashi, A. Ishikawa, H. Nagai, M. Saito, M. Maruyama, T. Takahashi, T. Ozawa, S. Tsuji, and H. Takahashi An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene Mov. Disord. 15 2000 884 888
85. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch. Neurol. 60 2003 1119 1122
86. A.N. Hegde, and A. DiAntonio Ubiquitin and the synapse Nat. Rev. Neurosci. 3 2002 854 861
87. F. Hernandez, M. Diaz-Hernandez, J. Avila, and J.J. Lucas Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo Trends Neurosci. 27 2004 66 69
88. A. Hershko, and A. Ciechanover The ubiquitin system Annu. Rev. Biochem. 67 1998 425 479
89. L. Hicke Protein regulation by monoubiquitin Nat. Rev. Mol. Cell. Biol. 2 2001 195 201
90. M. Hochstrasser Evolution and function of ubiquitin-like protein-conjugation systems Nat. Cell Biol. 2 2000 E153 E157
91. C. Hock, U. Konietzko, J.R. Streffer, J. Tracy, A. Signorell, B. Muller-Tillmanns, U. Lemke, K. Henke, E. Moritz, E. Garcia, M.A. Wollmer, D. Umbricht, D.J. de Quervain, M. Hofmann, A. Maddalena, A. Papassotiropoulos, and R.M. Nitsch Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease Neuron 38 2003 547 554
92. Y. Huang, X.Q. Liu, T. Wyss-Coray, W.J. Brecht, D.A. Sanan, and R.W. Mahley Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons Proc. Natl. Acad. Sci. U.S.A. 98 2001 8838 8843
93. J.T. Huse, D.S. Pijak, G.J. Leslie, V.M. Lee, and R.W. Doms Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme The Alzheimer's disease beta-secretase J. Biol. Chem. 275 2000 33729 33737
94. A.D. Husom, E.A. Peters, E.A. Kolling, N.A. Fugere, L.V. Thompson, and D.A. Ferrington Altered proteasome function and subunit composition in aged muscle Arch. Biochem. Biophys. 421 2004 67 76
95. D.H. Hyun, M. Lee, B. Halliwell, and P. Jenner Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins J. Neurochem. 86 2003 363 373
96. N. Ida, C.L. Masters, and K. Beyreuther Rapid cellular uptake of Alzheimer amyloid betaA4 peptide by cultured human neuroblastoma cells FEBS Lett. 394 1996 174 178
97. K. Imaizumi, K. Miyoshi, T. Katayama, T. Yoneda, M. Taniguchi, T. Kudo, and M. Tohyama The unfolded protein response and Alzheimer's disease Biochim. Biophys. Acta 1536 2001 85 96
98. Y. Inai, and M. Nishikimi Increased degradation of oxidized proteins in yeast defective in 26S proteasome assembly Arch. Biochem. Biophys. 404 2002 279 284
99. A. Ishikawa, and H. Takahashi Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism J. Neurol. 245 1998 P4 P9
100. J.L. Jankowsky, D.J. Fadale, J. Anderson, G.M. Xu, V. Gonzales, N.A. Jenkins, N.G. Copeland, M.K. Lee, L.H. Younkin, S.L. Wagner, S.G. Younkin, and D.R. Borchelt Mutant presenilins specifically elevate the levels of the 42 residue {beta}-amyloid peptide in vivo: evidence for augmentation of a 42-specific {gamma} secretase Hum. Mol. Genet. 13 2004 159 170
101. D.M. Janse, B. Crosas, D. Finley, and G.M. Church Localization to the proteasome is sufficient for degradation J. Biol. Chem. 279 2004 21415 21420
102. I. Jariel-Encontre, M. Pariat, F. Martin, S. Carillo, C. Salvat, and M. Piechaczyk Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26S proteasome J. Biol. Chem. 270 1995 11623 11627
103. Y.H. Jiang, D. Armstrong, U. Albrecht, C.M. Atkins, J.L. Noebels, G. Eichele, J.D. Sweatt, and A.L. Beaudet Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation Neuron 21 1998 799 811
104. G.V. Johnson, and C.D. Bailey Tau, where are we now? J. Alzheimers Dis. 4 2002 375 398
105. T. Kamitani, K. Kito, T. Fukuda-Kamitani, and E.T. Yeh Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1 J. Biol. Chem. 276 2001 46655 46660
106. C. Kaneko, S. Hatakeyama, M. Matsumoto, M. Yada, K. Nakayama, and K.I. Nakayama Characterization of the mouse gene for the U-box-type ubiquitin ligase UFD2a Biochem. Biophys. Res. Commun. 300 2003 297 304
107. J. Kanski, S. Varadarajan, M. Aksenova, and D.A. Butterfield Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity Biochim. Biophys. Acta 1586 2002 190 198
108. T. Katayama, K. Imaizumi, N. Sato, K. Miyoshi, T. Kudo, J. Hitomi, T. Morihara, T. Yoneda, F. Gomi, Y. Mori, Y. Nakano, J. Takeda, T. Tsuda, Y. Itoyama, O. Murayama, A. Takashima, P. St. George-Hyslop, M. Takeda, and M. Tohyama Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response Nat. Cell Biol. 1 1999 479 485
109. S. Keck, R. Nitsch, T. Grune, and O. Ullrich Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease J. Neurochem. 85 2003 115 122
110. J.N. Keller, J. Gee, and Q. Ding The proteasome in brain aging Ageing Res. Rev. 1 2002 279 293
111. J.N. Keller, K.B. Hanni, and W.R. Markesbery Impaired proteasome function in Alzheimer's disease J. Neurochem. 75 2000 436 439
112. J.N. Keller, K.B. Hanni, and W.R. Markesbery Possible involvement of proteasome inhibition in aging: implications for oxidative stress Mech. Ageing Dev. 113 2000 61 70
113. J.N. Keller, F.F. Huang, and W.R. Markesbery Decreased levels of proteasome activity and proteasome expression in aging spinal cord Neuroscience 98 2000 149 156
114. T.W. Kim, W.H. Pettingell, O.G. Hallmark, R.D. Moir, W. Wasco, and R.E. Tanzi Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells J. Biol. Chem. 272 1997 11006 11010
115. L.S. Kirschner, and C.A. Stratakis Structure of the human ubiquitin fusion gene Uba80 (RPS27a) and one of its pseudogenes Biochem. Biophys. Res. Commun. 270 2000 1106 1110
116. T. Kishino, M. Lalande, and J. Wagstaff UBE3A/E6-AP mutations cause Angelman syndrome Nat. Genet. 15 1997 70 73
117. A.F. Kisselev, T.N. Akopian, K.M. Woo, and A.L. Goldberg The sizes of peptides generated from protein by mammalian 26S and 20S proteasomes Implications for understanding the degradative mechanism and antigen presentation J. Biol. Chem. 274 1999 3363 3371
118. A.F. Kisselev, M. Garcia-Calvo, H.S. Overkleeft, E. Peterson, M.W. Pennington, H.L. Ploegh, N.A. Thornberry, and A.L. Goldberg The caspase-like sites of proteasomes: substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites J. Biol. Chem. 278 2003 35869 35877
119. W.E. Klunk, K. Panchalingam, R.J. McClure, J.A. Stanley, and J.W. Pettegrew Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4 Neurobiol. Aging 19 1998 511 515
120. M. Koegl, T. Hoppe, S. Schlenker, H.D. Ulrich, T.U. Mayer, and S. Jentsch A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly Cell 96 1999 635 644
121. T. Kudo, K. Iqbal, R. Ravid, D.F. Swaab, and I. Grundke-Iqbal Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels. Brain Res. 639 1994 1 7
122. Y.A. Lam, T.G. Lawson, M. Velayutham, J.L. Zweier, and C.M. Pickart A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal Nature 416 2002 763 767
123. Y.A. Lam, C.M. Pickart, A. Alban, M. Landon, C. Jamieson, R. Ramage, R.J. Mayer, and R. Layfield Inhibition of the ubiquitin-proteasome system in Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 97 2000 9902 9906
124. Y.A. Lam, W. Xu, G.N. DeMartino, and R.E. Cohen Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome Nature 385 1997 737 740
125. I. Lang-Rollin, H. Rideout, and L. Stefanis Ubiquitinated inclusions and neuronal cell death Histol. Histopathol. 18 2003 509 517
126. H. Laser, T.G. Mack, D. Wagner, and M.P. Coleman Proteasome inhibition arrests neurite outgrowth and causes "dying-back" degeneration in primary culture J. Neurosci. Res. 74 2003 906 916
127. C.M. Lauderback, J. Kanski, J.M. Hackett, N. Maeda, M.S. Kindy, and D.A. Butterfield Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner Brain Res. 924 2002 90 97
128. S.M. Laws, E. Hone, S. Gandy, and R.N. Martins Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription J. Neurochem. 84 2003 1215 1236
129. V.M. Lee Biomedicine Tauists and beta-aptists united - well almost! Science 293 2001 1446 1447
130. K. Lindsten, F.M. De Vrij, L.G. Verhoef, D.F. Fischer, F.W. Van Leeuwen, E.M. Hol, M.G. Masucci, and N.P. Dantuma Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation J. Cell Biol. 157 2002 417 427
131. K. Lindsten, V. Menendez-Benito, M.G. Masucci, and N.P. Dantuma A transgenic mouse model of the ubiquitin/proteasome system Nat. Biotechnol. 21 2003 897 902
132. Y. Liu, L. Fallon, H.A. Lashuel, Z. Liu, and P.T. Lansbury Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility Cell 111 2002 209 218
133. M. Lopez Salon, L. Morelli, E.M. Castano, E.F. Soto, and J.M. Pasquini Defective ubiquitination of cerebral proteins in Alzheimer's disease J. Neurosci. Res. 62 2000 302 310
134. M. Lopez-Salon, M. Alonso, M.R. Vianna, H. Viola, T. Mello e Souza, I. Izquierdo, J.M. Pasquini, and J.H. Medina The ubiquitin-proteasome cascade is required for mammalian long-term memory formation Eur. J. Neurosci. 14 2001 1820 1826
135. J.F. Loring, X. Wen, J.M. Lee, J. Seilhamer, and R. Somogyi A gene expression profile of Alzheimer's disease DNA Cell Biol. 20 2001 683 695
136. M.A. Lovell, W.D. Ehmann, M.P. Mattson, and W.R. Markesbery Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease Neurobiol. Aging 18 1997 457 461
137. J. Lowe, H. McDermott, M. Landon, R.J. Mayer, and K.D. Wilkinson Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases J. Pathol. 161 1990 153 160
138. T. Lu, Y. Pan, S.Y. Kao, C. Li, I. Kohane, J. Chan, and B.A. Yankner Gene regulation and DNA damage in the ageing human brain Nature 429 2004 883 891
139. S. Martin, J.R. Gee, A.J. Bruce-Keller, and J.N. Keller Loss of an individual proteasome subunit alters motor function but not cognitive function or ambulation in mice Neurosci. Lett. 357 2004 76 78
140. E. Masliah, M. Ellisman, B. Carragher, M. Mallory, S. Young, L. Hansen, R. DeTeresa, and R.D. Terry Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease J. Neuropathol. Exp. Neurol. 51 1992 404 414
141. E. Masliah, R.D. Terry, M. Alford, R. DeTeresa, and L.A. Hansen Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease Am. J. Pathol. 138 1991 235 246
142. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
143. M.P. Mattson, W. Fu, G. Waeg, and K. Uchida 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau Neuroreport 8 1997 2275 2281
144. P. May, Y.K. Reddy, and J. Herz Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain J. Biol. Chem. 277 2002 18736 18743
145. E.G. McGeer, and P.L. McGeer Inflammatory processes in Alzheimer's disease Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 741 749
146. J.P. McGrath, S. Jentsch, and A. Varshavsky UBA, 1, an essential yeast gene encoding ubiquitin-activating enzyme EMBO J. 10 1991 227 236
147. M.M. Mesulam Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles Neuron 24 1999 521 529
148. S. Miranda, C. Opazo, L.F. Larrondo, F.J. Munoz, F. Ruiz, F. Leighton, and N.C. Inestrosa The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease Prog. Neurobiol. 62 2000 633 648
149. D.J. Moore, V.L. Dawson, and T.M. Dawson Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses Neuromol. Med. 4 2003 95 108
150. H. Mori, J. Kondo, and Y. Ihara Ubiquitin is a component of paired helical filaments in Alzheimer's disease Science 235 1987 1641 1644
151. H. Mori, T. Kondo, M. Yokochi, H. Matsumine, Y. Nakagawa-Hattori, T. Miyake, K. Suda, and Y. Mizuno Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q Neurology 51 1998 890 892
152. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, K. Titani, and Y. Ihara Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments Neuron 10 1993 1151 1160
153. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, H. Yoshida, K. Titani, and Y. Ihara Proline-directed and non-proline-directed phosphorylation of PHF-tau J. Biol. Chem. 270 1995 823 829
154. M. Morishima-Kawashima, and Y. Ihara Alzheimer's disease: beta-Amyloid protein and tau J. Neurosci. Res. 70 2002 392 401
155. L. Mucke, E. Masliah, G.Q. Yu, M. Mallory, E.M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue High-level neuronal expression of Abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20 2000 4050 4058
156. A. Mudher, and S. Lovestone Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci. 25 2002 22 26
157. S. Muller, C. Hoege, G. Pyrowolakis, and S. Jentsch SUMO, ubiquitin's mysterious cousin Nat. Rev. Mol. Cell. Biol. 2 2001 202 210
158. S. Muller, and L.M. Schwartz Ubiquitin in homeostasis, development and disease Bioessays 17 1995 677 684
159. Y. Murakami, S. Matsufuji, S. Hayashi, N. Tanahashi, and K. Tanaka Degradation of ornithine decarboxylase by the 26S proteasome Biochem. Biophys. Res. Commun. 267 2000 1 6
160. Y. Murakami, S. Matsufuji, T. Kameji, S. Hayashi, K. Igarashi, T. Tamura, K. Tanaka, and A. Ichihara Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination Nature 360 1992 597 599
161. R.G. Nagele, M.R. D'Andrea, W.J. Anderson, and H.Y. Wang Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease Neuroscience 110 2002 199 211
162. A. Navon, and A.L. Goldberg Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome Mol. Cell 8 2001 1339 1349
163. R.A. Nixon, A.M. Cataldo, and P.M. Mathews The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review Neurochem. Res. 25 2000 1161 1172
164. J. Nunan, N.A. Williamson, A.F. Hill, M.F. Sernee, C.L. Masters, and D.H. Small Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein J. Neurosci. Res. 74 2003 378 385
165. S. Oddo, L. Billings, J.P. Kesslak, D.H. Cribbs, and F.M. LaFerla Abeta immunotherapy leads to clearance of early, but not late Hyperphosphorylated tau aggregates via the proteasome Neuron 43 2004 321 332
166. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
167. M. Orlowski, and S. Wilk Ubiquitin-independent proteolytic functions of the proteasome Arch. Biochem. Biophys. 415 2003 1 5
168. A. Ott, M.M. Breteler, F. van Harskamp, J.J. Claus, T.J. van der Cammen, D.E. Grobbee, and A. Hofman Prevalence of Alzheimer's disease and vascular
169. G.M. Pasinetti Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia J. Neurosci. Res. 65 2001 471 476
170. L.A. Pasquini, M. Besio Moreno, A.M. Adamo, J.M. Pasquini, and E.F. Soto Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells J. Neurosci. Res. 59 2000 601 611
171. S.H. Pasternak, J.W. Callahan, and D.J. Mahuran The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: reexamining the spatial paradox from a lysosomal perspective J. Alzheimers Dis. 6 2004 53 65
172. G.N. Patrick, B. Bingol, H.A. Weld, and E.M. Schuman Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs Curr. Biol. 13 2003 2073 2081
173. J. Peng, D. Schwartz, J.E. Elias, C.C. Thoreen, D. Cheng, G. Marsischky, J. Roelofs, D. Finley, and S.P. Gygi A proteomics approach to understanding protein ubiquitination Nat. Biotechnol. 21 2003 921 926
174. M. Perez, F. Hernandez, A. Gomez-Ramos, M. Smith, G. Perry, and J. Avila Formation of aberrant phosphotau fibrillar polymers in neural cultured cells Eur. J. Biochem. 269 2002 1484 1489
175. G. Perry, R. Friedman, G. Shaw, and V. Chau Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains Proc. Natl. Acad. Sci. U.S.A. 84 1987 3033 3036
176. L. Petrucelli, D. Dickson, K. Kehoe, J. Taylor, H. Snyder, A. Grover, M. De Lucia, E. McGowan, J. Lewis, G. Prihar, J. Kim, W.H. Dillmann, S.E. Browne, A. Hall, R. Voellmy, Y. Tsuboi, T.M. Dawson, B. Wolozin, J. Hardy, and M. Hutton CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation Hum. Mol. Genet. 13 2004 703 714
177. C.M. Pickart Back to the future with ubiquitin Cell 116 2004 181 190
178. J. Poirier, J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand, and S. Gauthier Apolipoprotein E polymorphism and Alzheimer's disease Lancet 342 1993 697 699
179. J.L. Price, and J.C. Morris So what if tangles precede plaques? Neurobiol. Aging 25 2004 721 723
180. J.H. Qiu, A. Asai, S. Chi, N. Saito, H. Hamada, and T. Kirino Proteasome inhibitors induce cytochrome c-caspase-3-like protease- mediated apoptosis in cultured cortical neurons J. Neurosci. 20 2000 259 265
181. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek, and A. Ferreira Tau is essential to beta -amyloid-induced neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 99 2002 6364 6369
182. K.L. Redman, and M. Rechsteiner Identification of the long ubiquitin extension as ribosomal protein S27a Nature 338 1989 438 440
183. E. Reits, J. Neijssen, C. Herberts, W. Benckhuijsen, L. Janssen, J.W. Drijfhout, and J. Neefjes A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation Immunity 20 2004 495 506
184. C. Richmond, C. Gorbea, and M. Rechsteiner Specific interactions between ATPase subunits of the 26S protease J. Biol. Chem. 272 1997 13403 13411
185. A.J. Rivett, S. Bose, P. Brooks, and K.I. Broadfoot Regulation of proteasome complexes by gamma-interferon and phosphorylation Biochimie 83 2001 363 366
186. A. Rocchi, S. Pellegrini, G. Siciliano, and L. Murri Causative and susceptibility genes for Alzheimer's disease: a review Brain Res. Bull 61 2003 1 24
187. D.R. Rosen Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 364 1993 362
188. A.D. Roses Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease Ann. Neurol. 38 1995 6 14
189. K. Saigoh, Y.L. Wang, J.G. Suh, T. Yamanishi, Y. Sakai, H. Kiyosawa, T. Harada, N. Ichihara, S. Wakana, T. Kikuchi, and K. Wada Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice Nat. Genet. 23 1999 47 51
190. A. Salehi, E.J. Dubelaar, M. Mulder, and D.F. Swaab Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent Proc. Natl. Acad. Sci. U.S.A. 95 1998 11445 11449
191. N. Sato, F. Urano, J. Yoon Leem, S.H. Kim, M. Li, D. Donoviel, A. Bernstein, A.S. Lee, D. Ron, M.L. Veselits, S.S. Sisodia, and G. Thinakaran Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression Nat. Cell Biol. 2 2000 863 870
192. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan, and M.J. Alberts Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472
193. D. Schenk Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning Nat. Rev. Neurosci. 3 2002 824 828
194. A. Schmitz, A. Schneider, M.P. Kummer, and V. Herzog Endoplasmic reticulum-localized amyloid beta-peptide is degraded in the cytosol by two distinct degradation pathways Traffic 5 2004 89 101
195. B. Schonheit, R. Zarski, and T.G. Ohm Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology Neurobiol. Aging 25 2004 697 711
196. D.C. Schwartz, and M. Hochstrasser A superfamily of protein tags: ubiquitin, SUMO and related modifiers Trends Biochem. Sci. 28 2003 321 328
197. C.A. Semple The comparative proteomics of ubiquitination in mouse Genome Res. 13 2003 1389 1394
198. R.J. Sheaff, J.D. Singer, J. Swanger, M. Smitherman, J.M. Roberts, and B.E. Clurman Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination Mol. Cell 5 2000 403 410
199. H. Shimura, M.G. Schlossmacher, N. Hattori, M.P. Frosch, A. Trockenbacher, R. Schneider, Y. Mizuno, K.S. Kosik, and D.J. Selkoe Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease Science 293 2001 263 269
200. H. Shimura, D. Schwartz, S.P. Gygi, and K.S. Kosik CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival J. Biol. Chem. 279 2004 4869 4876
201. R. Shringarpure, and K.J. Davies Protein turnover by the proteasome in aging and disease Free Radic. Biol. Med. 32 2002 1084 1089
202. R. Shringarpure, T. Grune, J. Mehlhase, and K.J. Davies Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome J. Biol. Chem. 278 2003 311 318
203. R. Shringarpure, T. Grune, N. Sitte, and K.J. Davies 4-Hydroxynonenal- modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease Cell. Mol. Life Sci. 57 2000 1802 1809
204. S. Song, S.Y. Kim, Y.M. Hong, D.G. Jo, J.Y. Lee, S.M. Shim, C.W. Chung, S.J. Seo, Y.J. Yoo, J.Y. Koh, M.C. Lee, A.J. Yates, H. Ichijo, and Y.K. Jung Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity Mol. Cell 12 2003 553 563
205. S.D. Speese, N. Trotta, C.K. Rodesch, B. Aravamudan, and K. Broadie The ubiquitin proteasome system acutely regulates presynaptic protein turnover and synaptic efficacy Curr. Biol. 13 2003 899 910
206. J. Spence, S. Sadis, A.L. Haas, and D. Finley A ubiquitin mutant with specific defects in DNA repair and multiubiquitination Mol. Cell. Biol. 15 1995 1265 1273
207. M.G. Spillantini, and M. Goedert Tau protein pathology in neurodegenerative diseases Trends Neurosci. 21 1998 428 433
208. A. Stieber, Z. Mourelatos, and N.K. Gonatas In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic Am. J. Pathol. 148 1996 415 426
209. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, S. Rothacher, B. Ledermann, K. Burki, P. Frey, P.A. Paganetti, C. Waridel, M.E. Calhoun, M. Jucker, A. Probst, M. Staufenbiel, and B. Sommer Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc. Natl. Acad. Sci. U.S.A. 94 1997 13287 13292
210. C.I. Sze, J.C. Troncoso, C. Kawas, P. Mouton, D.L. Price, and L.J. Martin Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease J. Neuropathol. Exp. Neurol. 56 1997 933 944
211. 2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26S proteasomes without ubiquitination J. Biol. Chem. 275 2000 20295 20301
212. C.Y. Teoh, and K.J. Davies Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis Arch. Biochem. Biophys. 423 2004 88 96
213. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
214. J.S. Thrower, L. Hoffman, M. Rechsteiner, and C.M. Pickart Recognition of the polyubiquitin proteolytic signal EMBO J. 19 2000 94 102
215. G.K. Tofaris, R. Layfield, and M.G. Spillantini Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome FEBS Lett. 509 2001 22 26
216. G.G. Turrigiano A recipe for ridding synapses of the ubiquitous AMPA receptor Trends Neurosci. 25 2002 597 598
217. F.W. Van Leeuwen, D.P. de Kleijn, H.H. van den Hurk, A. Neubauer, M.A. Sonnemans, J.A. Sluijs, S. Köycü, R.D. Ramdjielal, A. Salehi, G.J. Martens, F.G. Grosveld, J. Peter, H. Burbach, and E.M. Hol Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients Science 279 1998 242 247
218. M.E. Van Welsem, J.A. Hogenhuis, V. Meininger, W.P. Metsaars, J.J. Hauw, and D. Seilhean The relationship between Bunina bodies, skein-like inclusions and neuronal loss in amyotrophic lateral sclerosis Acta Neuropathol. (Berl.) 103 2002 583 589
219. R. Varadan, O. Walker, C. Pickart, and D. Fushman Structural properties of polyubiquitin chains in solution J. Mol. Biol. 324 2002 637 647
220. A. Varshavsky The ubiquitin system Trends Biochem. Sci. 22 1997 383 387
221. G. Wang, Y. Zhang, B. Chen, and J. Cheng Preliminary studies on Alzheimer's disease using cDNA microarrays Mech. Ageing Dev. 124 2003 115 124
222. R.J. Watts, E.D. Hoopfer, and L. Luo Axon pruning during Drosophila metamorphosis Evidence for local degeneration and requirement of the ubiquitin-proteasome system Neuron 38 2003 871 885
223. A.M. Weissman Regulating protein degradation by ubiquitination Immunol. Today 18 1997 189 198
224. C. Wenner, S. Lorkowski, T. Engel, and P. Cullen Apolipoprotein E in macrophages and hepatocytes is degraded via the proteasomal pathway Biochem. Biophys. Res. Commun. 282 2001 608 614
225. F.G. Whitby, E.I. Masters, L. Kramer, J.R. Knowlton, Y. Yao, C.C. Wang, and C.P. Hill Structural basis for the activation of 20S proteasomes by 11S regulators Nature 408 2000 115 120
226. F.G. Whitby, G. Xia, C.M. Pickart, and C.P. Hill Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes J. Biol. Chem. 273 1998 34983 34991
227. K.D. Wilkinson Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome Semin. Cell Dev. Biol. 11 2000 141 148
228. C. Wojcik, and G.N. DeMartino Intracellular localization of proteasomes Int. J. Biochem. Cell Biol. 35 2003 579 589
229. D.S. Yang, J.D. Smith, Z. Zhou, S.E. Gandy, and R.N. Martins Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma J. Neurochem. 68 1997 721 725
230. P. Young, Q. Deveraux, R.E. Beal, C.M. Pickart, and M. Rechsteiner Characterization of two polyubiquitin binding sites in the 26S protease subunit 5a J. Biol. Chem. 273 1998 5461 5467
231. Y. Zhang, J. Gao, K.K. Chung, H. Huang, V.L. Dawson, and T.M. Dawson Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1 Proc. Natl. Acad. Sci. U.S.A. 97 2000 13354 13359
232. Y. Zhang, R. McLaughlin, C. Goodyer, and A. LeBlanc Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons J. Cell Biol. 156 2002 519 529
233. Y. Zhao, A.N. Hegde, and K.C. Martin The ubiquitin proteasome system functions as an inhibitory constraint on synaptic strengthening Curr. Biol. 13 2003 887 898
234. X. Zhu, A.K. Raina, H.G. Lee, G. Casadesus, M.A. Smith, and G. Perry Oxidative stress signalling in Alzheimer's disease. Brain Res. 1000 2004 32 39
235. X. Zhu, A.K. Raina, G. Perry, and M.A. Smith Alzheimer's disease: the two-hit hypothesis Lancet Neurol. 3 2004 219 226